MASECO Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MASECO Private Wealth's ARKG Position: Q1 2026 in Review
MASECO Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 65 shares — an estimated $1.88K sold.
MASECO Private Wealth first reported a position in ARKG in Q2 2025 and held it in 3 quarters. The position peaked at $1.88K in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- MASECO Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- MASECO Private Wealth sold 65 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.88K.
- MASECO Private Wealth first reported a position in ARK Genomic Revolution ETF in Q2 2025 and held it in 3 quarters.
- MASECO Private Wealth's ARK Genomic Revolution ETF position peaked at $1.88K in Q4 2025.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on MASECO Private Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.